During the past decade, Kure Kyosai Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kure Kyosai Hospital" are "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Crohn Disease" (1 trials), "Pulmonary Arterial Hypertension" (1 trials), "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Kure Kyosai Hospital" in a lesser frequency.

Most popular intervention types in "Kure Kyosai Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Macitentan 10 mg" (2 trials), "FDC macitentan/tadalafil" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kure Kyosai Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Kure Kyosai Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kure Kyosai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kure Kyosai Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".